BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7961807)

  • 1. Identification of cell type-dependent enhancer core element located in the 3'-downstream region of the human angiotensinogen gene.
    Nibu Y; Takahashi S; Tanimoto K; Murakami K; Fukamizu A
    J Biol Chem; 1994 Nov; 269(46):28598-605. PubMed ID: 7961807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cell type-dependent enhancer core element is located in exon 5 of the human angiotensinogen gene.
    Nibu Y; Tanimoto K; Takahashi S; Ono H; Murakami K; Fukamizu A
    Biochem Biophys Res Commun; 1994 Dec; 205(2):1102-8. PubMed ID: 7802638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cis-acting DNA element located between TATA box and transcription initiation site is critical in response to regulatory sequences in human angiotensinogen gene.
    Yanai K; Nibu Y; Murakami K; Fukamizu A
    J Biol Chem; 1996 Jul; 271(27):15981-6. PubMed ID: 8663141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATF-like element contributes to hepatic activation of human angiotensinogen promoter.
    Yanai K; Murakami K; Fukamizu A
    Biochem Biophys Res Commun; 1997 Aug; 237(1):158-62. PubMed ID: 9266849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and expression of the human angiotensinogen gene. Identification of a unique and highly active promoter.
    Fukamizu A; Takahashi S; Seo MS; Tada M; Tanimoto K; Uehara S; Murakami K
    J Biol Chem; 1990 May; 265(13):7576-82. PubMed ID: 1692023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanism of transcriptional activation of angiotensinogen gene by proximal promoter.
    Tamura K; Umemura S; Ishii M; Tanimoto K; Murakami K; Fukamizu A
    J Clin Invest; 1994 Apr; 93(4):1370-9. PubMed ID: 8163641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of an upstream enhancer within a functional promoter of the human leukemia inhibitory factor receptor gene and its alternative promoter usage.
    Wang Z; Melmed S
    J Biol Chem; 1997 Oct; 272(44):27957-65. PubMed ID: 9346946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic enhansons located within an acute phase responsive enhancer modulate glucocorticoid induction of angiotensinogen gene transcription.
    Brasier AR; Ron D; Tate JE; Habener JF
    Mol Endocrinol; 1990 Dec; 4(12):1921-33. PubMed ID: 1707127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proximal and core DNA elements are required for efficient angiotensinogen promoter activation during adipogenic differentiation.
    Tamura K; Tanimoto K; Ishii M; Murakami K; Fukamizu A
    J Biol Chem; 1993 Jul; 268(20):15024-32. PubMed ID: 8325878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The function of conserved elements in the promoter of the mouse angiotensinogen gene.
    Congiu M; Clouston WM; Fernley RT; Richards RI
    J Mol Endocrinol; 1992 Aug; 9(1):19-29. PubMed ID: 1515023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential action of AGCF2 upon cell type-dependent expression of human angiotensinogen gene.
    Yanai K; Matsuyama S; Murakami K; Fukamizu A
    FEBS Lett; 1997 Jul; 412(2):285-9. PubMed ID: 9256236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of CAAT/enhancer binding protein in IL-6 regulation of angiotensinogen gene expression].
    Zhao Y; Shen K
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Jun; 15(3):129-32. PubMed ID: 9621116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of an essential cis-acting element (TR2-PACE) in the 5' promoter of human TR2 orphan receptor gene.
    Lin DL; Chang C
    Endocrine; 2000 Feb; 12(1):89-97. PubMed ID: 10855696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human thyroxine-binding globulin gene: complete sequence and transcriptional regulation.
    Hayashi Y; Mori Y; Janssen OE; Sunthornthepvarakul T; Weiss RE; Takeda K; Weinberg M; Seo H; Bell GI; Refetoff S
    Mol Endocrinol; 1993 Aug; 7(8):1049-60. PubMed ID: 8232304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple cis-acting DNA regulatory elements mediate hepatic angiotensinogen gene expression.
    Brasier AR; Tate JE; Ron D; Habener JF
    Mol Endocrinol; 1989 Jun; 3(6):1022-34. PubMed ID: 2544800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Members of the nuclear factor 1 transcription factor family regulate rat 3alpha-hydroxysteroid/dihydrodiol dehydrogenase (3alpha-HSD/DD AKR1C9) gene expression: a member of the aldo-keto reductase superfamily.
    Hung CF; Penning TM
    Mol Endocrinol; 1999 Oct; 13(10):1704-17. PubMed ID: 10517672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a second region upstream of the mouse heme oxygenase-1 gene that functions as a basal level and inducer-dependent transcription enhancer.
    Alam J; Camhi S; Choi AM
    J Biol Chem; 1995 May; 270(20):11977-84. PubMed ID: 7538129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver-specific enhancer of the glucokinase gene.
    Iynedjian PB; Marie S; Wang H; Gjinovci A; Nazaryan K
    J Biol Chem; 1996 Nov; 271(46):29113-20. PubMed ID: 8910567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cAMP increases the expression of human angiotensinogen gene through a combination of cyclic AMP responsive element binding protein and a liver specific transcription factor.
    Narayanan CS; Cui Y; Kumar S; Kumar A
    Mol Cell Biochem; 2000 Sep; 212(1-2):81-90. PubMed ID: 11108139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a liver preference enhancer element of the rat hemopexin gene and its interaction with nuclear factors.
    Satoh H; Nagae Y; Immenschuh S; Satoh T; Muller-Eberhard U
    J Biol Chem; 1994 Mar; 269(9):6851-8. PubMed ID: 8120047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.